Charles Witherspoon - 20 Feb 2026 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP & Treasurer
Signature
/s/ Louis Lalli, as an agent for Charles Witherspoon
Issuer symbol
WST
Transactions as of
20 Feb 2026
Net transactions value
-$5,321
Form type
4
Filing time
23 Feb 2026, 17:41:39 UTC
Previous filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Witherspoon Charles VP & Treasurer 530 HERMAN O. WEST DRIVE, EXTON /s/ Louis Lalli, as an agent for Charles Witherspoon 23 Feb 2026 0001731739

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise +60 +4.4% 1,430 20 Feb 2026 Direct F1
transaction WST Common Stock Tax liability $5,321 -22 -1.5% $241.12 1,408 20 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Rst. Stock Unit Options Exercise $0 -60 -25% $0.000000 178 20 Feb 2026 Common Stock 60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year.